Jenuppic's first-quarter order volume increased by 74% year-over-year

Investing.com — German optoelectronics company Jenoptik AG (stock code: JEN GR) announced on Tuesday that in the first quarter of this year, its order volume reached €357 million, up significantly by 74% from €205 million in the same period last year.

This growth was mainly driven by the semiconductor and advanced manufacturing business segments, with a major order playing a key role. The biophotonics segment also saw a synchronized increase in order volume in the medical technology, life sciences, and defense markets.

First-quarter revenue was €241 million, down slightly by 1% year over year. Earnings before interest, taxes, depreciation, and amortization (EBITDA) was €44.4 million, up 22.5% year over year. EBITDA margin rose to 18.4%, compared with 14.9% in the first quarter of 2025.

The improvement in profit margins was attributed to optimization of the product mix, the elimination of one-off costs related to the relocation of the new Dresden plant, and continued cost-reduction and efficiency measures.

This quarter’s book-to-bill ratio was 1.48, higher than 0.84 in the same period last year. Backlog increased from €591 million at the end of 2025 to €719.2 million.

Due to the impact of increased operating capital driven by rising demand, free cash flow before interest and taxes decreased from €28.9 million in the same period last year to €15.9 million.

Jenoptik maintained its full-year 2026 performance outlook unchanged, expecting revenue to grow in the low single digits based on the 2025 figure of €1.046 billion, with an EBITDA margin target range of 19% to 21%, higher than last year’s 18.4%. Capital expenditures are expected to be slightly lower than last year’s €77.4 million.

The company’s Chief Financial Officer said that the strong momentum in current order volume is difficult to sustain at this level, but it has already laid a solid foundation for the 2026 fiscal year.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.